Moneyview IPO: GMP, allotment date, listing cues

Moneyview’s mainboard IPO stayed in focus across Reddit and social feeds as investors tracked subscription momentum, allotment timing, and the grey market premium (GMP) for listing cues.

Moneyview IPO snapshot investors are sharing

Posts widely describe Moneyview IPO as a book-built issue sized at ₹1,091.68 crore. The offer is discussed as a mix of fresh issue and offer for sale, with many users focusing on how that split may affect post-issue supply. The IPO is repeatedly described as slated for listing on both NSE and BSE. Multiple trackers circulating on social media also mention a tentative listing date of October 1, 2026. The price band most commonly quoted is ₹32 to ₹34 per share. Conversations also highlight that the face value is ₹1 per share. Several posts shared a total issue size figure of 32,10,82,435 shares. The following table compiles the most repeated details from the shared posts.

Key dates: open, close, allotment, listing

The bidding window is consistently stated as September 24 to September 28, 2026. The allotment date is repeatedly mentioned as September 29, 2026, in multiple social timelines. Several posts also align on refunds initiation being September 29, 2026. Demat credit is commonly listed as September 30, 2026 in the same timelines. Listing is widely circulated as October 1, 2026, with the qualifier that it is tentative. Some users are watching these dates closely because the GMP updates are being posted alongside them. In the discussions, allotment and demat credit are treated as the key checkpoints before listing day. Investors also flagged that different trackers can update the timeline formatting differently, but the dates broadly matched.

Issue structure: fresh issue versus OFS

Social posts describe the IPO as a combination of a ₹750 crore fresh issue and a ₹341.68 crore offer for sale. The fresh issue is also expressed in share terms as 22.06 crore shares aggregating to ₹750 crore. The OFS is similarly described as 10.05 crore shares aggregating to ₹341.68 crore. Some posts rounded the overall issue to about ₹1,092 crore, while others used ₹1,091.61 crore, but the dominant figure repeated was ₹1,091.68 crore. The OFS number also appeared as 10.04 crore shares in a few trackers, while many posts used 10.05 crore. Discussion threads often separated the two because fresh issue proceeds are viewed differently from OFS flows. A few posts also stated that funds are intended to expand Moneyview’s lending business and enhance operational capabilities. That usage line is being repeated as a key narrative point in retail threads.

Price band and lot size: what retail investors calculated

The price band is consistently cited as ₹32 to ₹34 per share. Most posts list the application lot size at 441 shares for retail. Based on the upper price band, many users computed the minimum retail application amount as ₹14,994 for one lot. A smaller set of posts mentioned a different bid lot number of 176 shares, which created confusion in some comment chains. However, the same feeds that discussed retail minimum investment typically paired it with the 441-share lot. Users also shared screenshots of calculators showing ₹14,994 at ₹34 for 441 shares. The focus in these threads was less on valuation and more on the mechanics of placing bids correctly. Some comments reminded others that the upper band is used for these quick calculations. The repeated advice in threads was to double-check the lot size shown by the broker platform before bidding.

Subscription talk: strong demand, but varying snapshots

The most-circulated headline figure in social posts is that the issue ended with 98.46 times subscription. Those posts attribute the demand surge mainly to QIB and NII participation. In the same cluster of updates, users quoted bids for about 2,290 crore shares against 23.25 crore shares on offer. Another set of posts shared a different snapshot, stating bids for 33,48,61,002 shares against 23,25,24,175 shares available. Some mid-window updates also circulated an overall subscription of 66.57x, which may reflect a different point in time rather than the final tally. Because these are reposted from multiple trackers, investors on Reddit discussed that subscription numbers can shift quickly near the close. The consistent theme across posts is that demand was described as strong. Users tracking allotment odds were particularly focused on the retail portion implications, even when exact category-wise numbers were not pasted. The most repeated final framing remained the 98.46x figure with QIB and NII leadership.

Anchor allocation: what posts highlighted

A specific data point widely shared is that the board finalised anchor allocation on September 23, 2026. Posts state that 96,324,729 equity shares were allocated to anchor investors at ₹34 per share. Another frequently repeated detail is the mutual fund participation breakdown. Social updates claimed 69,632,136 equity shares, or 72.29 percent of the anchor allocation, went to seven domestic mutual funds through 14 schemes. Reddit users discussed this as a sentiment marker rather than a short-term price signal. Some posts used the anchor detail to argue that institutional interest was visible even before the public book closed. Others cautioned that anchor allocation itself does not guarantee listing performance. Still, the precision of the anchor numbers made them travel widely across feeds. The anchor price being at the top end of the band was also noted repeatedly. Overall, anchor allocation became one of the most-cited factual blocks in the social summary posts.

GMP signals: ₹12 to ₹14.5 and what it implies

The grey market premium numbers shared on social media were not identical across posts. Several updates cited a GMP around ₹14, while another quoted ₹14.5 on September 30, 2026. A separate line in circulation said the GMP was revised to ₹12, with an estimated listing price of ₹46 when added to the ₹34 cap price. Using GMP of ₹14 with the upper band of ₹34, multiple posts implied an estimated listing price around ₹48. Some posts also described a 37.5 percent GMP-based signal, implying an estimated listing price of about ₹46.75. Another snippet framed ₹14 as about 42.94 percent over the upper issue price, while the ₹14.5 update was shown as 42.65 percent above issue price. Because GMP is an informal indicator, commenters treated it as a sentiment gauge rather than a forecast. The practical takeaway in most threads was that GMP was positive but moving, and different trackers were publishing different prints.

Allotment status: what investors are checking on Sep 29

The basis of allotment is expected to be finalised on September 29, 2026, according to multiple shared timelines. This date became the main checkpoint for retail applicants looking to confirm allotment outcomes. Social posts also placed refunds initiation on September 29, 2026, in the same schedule. Many users are watching for demat credit on September 30, 2026 as a secondary confirmation before listing. Several threads discussed that broker and registrar updates may not appear at the same moment for everyone. The most repeated approach was to track the allotment status once the basis is finalised. Users also compared notes on how quickly refund unblocking may reflect in bank accounts after the stated date. Some posts mention “funds unblock or debit” around October 1, 2026 in specific tracker formats, adding to timing confusion. Despite the formatting differences, the dominant narrative is that September 29 is the key allotment date to watch.

Listing day expectations: NSE, BSE, and the implied range

The tentative listing date shared across trackers is October 1, 2026, on both NSE and BSE. Investors used the upper issue price of ₹34 as the anchor point for quick listing math in comment threads. With GMP prints ranging from ₹12 to ₹14.5, the implied listing price chatter clustered roughly between ₹46 and ₹48.5. Several posts explicitly computed ₹48.5 using ₹34 plus ₹14.5. Others used ₹34 plus ₹14 to arrive near ₹48. A separate widely shared estimate used a 37.5 percent signal to suggest around ₹46.75. Some early lines also circulated a lower implied figure by stating an indicative listing price “around ₹14 against the upper issue price of ₹34,” which appears to be a wording mismatch rather than a consistent calculation. Reddit commenters repeatedly noted that GMP can change sharply closer to listing. The most factual point in the discussion remains that the issue is scheduled to list on October 1, 2026, while the listing price is not known until market discovery.

What stood out on social: contradictions and how to read them

A consistent pattern in the social chatter is that the same IPO details are reposted with small differences. Issue size was shared as ₹1,091.68 crore most often, but also appeared as ₹1,091.61 crore and rounded as ₹1,092 crore. Lot size was commonly presented as 441 shares, but one post listed a 176-share bid lot, prompting confusion. Subscription was widely cited at 98.46x as a closing figure, while 66.57x appeared as a snapshot from a different time. GMP was shown at ₹12, ₹13, ₹14, and ₹14.5 across different dates and sources. These variations led many Reddit users to compare multiple trackers rather than rely on a single screenshot. Commenters also reminded each other that GMP is unofficial and not a regulated data point. The strongest alignment across posts is on the core timetable: open September 24, close September 28, allotment September 29, and listing October 1, 2026. For investors, the most useful takeaway from the chatter is to separate fixed IPO terms from moving indicators like subscription snapshots and GMP prints.